Display options
Cite
Chudasama A, Patel V, Nivsarkar M, et al. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res. 2011;2(1):30-8doi: 10.4103/2231-4040.79802.
Chudasama, A., Patel, V., Nivsarkar, M., Vasu, K., & Shishoo, C. (2011). Investigation of microemulsion system for transdermal delivery of itraconazole. Journal of advanced pharmaceutical technology & research, 2(1), 30-8. https://doi.org/10.4103/2231-4040.79802
Chudasama, Arpan, et al. "Investigation of microemulsion system for transdermal delivery of itraconazole." Journal of advanced pharmaceutical technology & research vol. 2,1 (2011): 30-8. doi: https://doi.org/10.4103/2231-4040.79802
Chudasama A, Patel V, Nivsarkar M, Vasu K, Shishoo C. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res. 2011 Jan;2(1):30-8. doi: 10.4103/2231-4040.79802. PMID: 22171289; PMCID: PMC3217682.
Copy Download .nbib Format: NLM
Share it on

J Adv Pharm Technol Res. 2011 Jan;2(1):30-8. doi: 10.4103/2231-4040.79802.

Investigation of microemulsion system for transdermal delivery of itraconazole.

Journal of advanced pharmaceutical technology & research

Arpan Chudasama, Vineetkumar Patel, Manish Nivsarkar, Kamala Vasu, Chamanlal Shishoo

Affiliations

  1. Department of Pharmaceutics, B V Patel PERD Centre, Ahmedabad, Gujarat, India.

PMID: 22171289 PMCID: PMC3217682 DOI: 10.4103/2231-4040.79802

Abstract

A new oil-in-water microemulsion-based (ME) gel containing 1% itraconazole (ITZ) was developed for topical delivery. The solubility of ITZ in oils and surfactants was evaluated to identify potential excipients. The microemulsion existence ranges were defined through the construction of the pseudoternary phase diagrams. The optimized microemulsion was characterized for its morphology and particle size distribution. The optimized microemulsion was incorporated into polymeric gels of Lutrol F127, Xanthan gum, and Carbopol 934 for convenient application and evaluated for pH, drug content, viscosity, and spreadability. In vitro drug permeation of ME gels was determined across excised rat skins. Furthermore, in vitro antimycotic inhibitory activity of the gels was conducted using agar-cup method and Candida albicans as a test organism. The droplet size of the optimized microemulsion was found to be <100 nm. The optimized Lutrol F 127 ME gel showed pH in the range of 5.68±0.02 and spreadability of 5.75±1.396 gcm/s. The viscosity of ME gel was found to be 1805.535±542.4 mPa s. The permeation rate (flux) of ITZ from prepared ME gel was found to be 4.234 μg/cm/h. The release profile exhibited diffusion controlled mechanism of drug release from ME ITZ gel. The developed ME gels were nonirritant and there was no erythema or edema. The antifungal activity of ITZ showed the widest zone of inhibition with Lutrol F127 ME gel. These results indicate that the studied ME gel may be a promising vehicle for topical delivery of ITZ.

Keywords: Antifungal; microemulsion; permeability; phase diagram; transdermal

References

  1. J Control Release. 2004 Mar 5;95(2):257-65 - PubMed
  2. J Am Acad Dermatol. 1996 Jan;34(1):110-5 - PubMed
  3. J Pharm Sci. 1962 Aug;51:802-4 - PubMed
  4. Int J Pharm. 2004 Mar 1;271(1-2):11-9 - PubMed
  5. J Antimicrob Chemother. 1999 Mar;43(3):321-31 - PubMed
  6. J Control Release. 2006 Jan 10;110(2):332-338 - PubMed
  7. J Control Release. 2000 Dec 3;69(3):421-33 - PubMed
  8. Adv Drug Deliv Rev. 2000 Dec 6;45(1):89-121 - PubMed
  9. Drug Saf. 2000 Jan;22(1):33-52 - PubMed
  10. Drug Dev Ind Pharm. 2006 Sep;32(8):911-8 - PubMed
  11. Chem Pharm Bull (Tokyo). 2000 Jun;48(6):798-801 - PubMed
  12. Clin Infect Dis. 1992 Mar;14 Suppl 1:S161-9 - PubMed
  13. Clin Infect Dis. 1992 Mar;14 Suppl 1:S43-53 - PubMed
  14. N Engl J Med. 1994 Jan 27;330(4):263-72 - PubMed
  15. J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S60-3 - PubMed
  16. Mycoses. 1988 Sep;31(9):476-85 - PubMed
  17. Rev Infect Dis. 1987 Jan-Feb;9 Suppl 1:S94-9 - PubMed
  18. Rev Infect Dis. 1987 Jan-Feb;9 Suppl 1:S43-6 - PubMed
  19. J Antimicrob Chemother. 1991 Oct;28(4):555-60 - PubMed
  20. J Am Pharm Assoc Am Pharm Assoc. 1956 Apr;45(4):212-8 - PubMed
  21. Crit Rev Ther Drug Carrier Syst. 1999;16(5):461-521 - PubMed
  22. Int J Pharm. 2008 Feb 12;349(1-2):283-90 - PubMed
  23. Drugs. 1989 Mar;37(3):310-44 - PubMed
  24. J Pharm Sci. 1967 Feb;56(2):200-7 - PubMed
  25. Int J Pharm. 2008 Sep 1;361(1-2):177-88 - PubMed
  26. Int J Pharm. 2003 Apr 30;256(1-2):65-73 - PubMed
  27. Am J Clin Dermatol. 2002;3(2):71-81 - PubMed
  28. J Biomed Mater Res. 1972 Nov;6(6):571-82 - PubMed
  29. J Pharm Pharmacol. 1998 Apr;50(4):413-8 - PubMed
  30. AAPS PharmSciTech. 2002;3(4):E35 - PubMed
  31. Arch Pharm Res. 2006 Nov;29(11):1055-60 - PubMed
  32. Mycoses. 1989;32 Suppl 1:67-87 - PubMed
  33. J Am Acad Dermatol. 1990 Sep;23(3 Pt 2):607-14 - PubMed
  34. J Control Release. 2000 Jul 3;67(2-3):191-202 - PubMed
  35. Chem Pharm Bull (Tokyo). 1984 Oct;32(10):4205-8 - PubMed

Publication Types